Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Lexaria Bioscience Corp. began developing its DehydraTECH™ technology in 2014 and has since strengthened and broadened the technology to an unprecedented degree. Lexaria is a global leader in enhancing the speed and efficiency of orally-delivered fat-soluble active molecules and drugs. Lexaria has also demonstrated early-stage effectiveness in improving delivery through human skin for the potential development of topically...
Lexaria Bioscience Corp. began developing its DehydraTECH™ technology in 2014 and has since strengthened and broadened the technology to an unprecedented degree. Lexaria is a global leader in enhancing the speed and efficiency of orally-delivered fat-soluble active molecules and drugs. Lexaria has also demonstrated early-stage effectiveness in improving delivery through human skin for the potential development of topically-administered products, including patches, creams and lotions. Lexaria’s technology is currently being evaluated for improved delivery characteristics of antiviral drugs in the global fight against COVID-19.

List your booth number for exhibitions, ask us